Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02504
Species: Homo sapiens
Position : chr8:129180000-129190000
Year: 2025
Title: Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: diffuse large B-cell lymphoma
PMID:  40067173
MONDO: MONDO:0018905
Tissue: lymph node
Tissue Ontology ID: UBERON:0000029
Cell Source: Karpas-422
CVCL ID: CVCL_1325
Cell Type: B cell
Cell Ontology ID: CL:0000236
Experiment Type: Enhancer activity assay, Functional perturbation assay
High Throughput Method: ChIP-seq, ATAC-seq, RNA-seq
Low Throughput Method: CRISPRi, Luciferase Reporter Assay, RT-RT-qPCR
About Target Gene
Target gene : MYC
About TF
TF name : POU2F2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
POU2F2 BCR signaling pathway pid 70
POU2F2 RNA polymerase II transcribes snRNA genes reactome 70
POU2F2 Validated transcriptional targets of deltaNp63 isoforms pid 47
Enhancer Associated Network
Overlapping Enhancers (hg19) 9 found
Enhancer ID Position Tissue Cell Disease
E_00951 chr8:129166547-129190290 lung malignant cell lung adenocarcinoma
E_00974 chr8:129166547-129190290 lung malignant cell lung adenocarcinoma
E_00975 chr8:129166547-129190290 lung malignant cell lung adenocarcinoma
E_02502 chr8:129180000-129190000 lymph node B cell diffuse large B-cell lymphoma
E_02503 chr8:129180000-129190000 lymph node B cell diffuse large B-cell lymphoma
E_00949 chr8:129188417-129189959 lung malignant cell lung adenocarcinoma
E_00950 chr8:129188417-129189959 lung malignant cell lung adenocarcinoma
E_01020 chr8:129188417-129189959 lymph node malignant cell lung adenocarcinoma
E_01025 chr8:129188417-129189959 lung club cell lung adenocarcinoma
Expression of Target Genes for the Enhancer